Draft of Project 1

The draft of my quick reference guide is finally complete! The QRG is supposed to highlight the controversy over whether drugs for multiple sclerosis are priced too high. These drug treatments often cost over $60,000, and are necessary for people with MS who wish to slow down the progression of their disease. On the other hand, pharmaceuticals argue that if the don't get a proper return on investment, there will be less incentive for future innovations in biomedicine. My goal this week is portray the debate more in-depth, and really highlight the major stakeholders clearly.

Here it is!